ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HYPD vs CNTB // PIOTROSKI F-SCORE QUALITY

Hyperion DeFi Inc. (NASDAQ) VS. Connect Biopharma Holdings Limited (NASDAQ) • 15-METRIC TALLY: HYPD 3 — CNTB 1
▲ PIOTROSKI F-SCORE QUALITY LEADER: HYPD
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HYPD VS. CNTB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HYPD CNTB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% -65.00% +245.00 HYPD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 5/9 2/9 +3.00 HYPD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.4 33.2 +16.20 HYPD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $49.7M $50.5M -$793.2K CNTB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HYPD REV CNTB REV HYPD GROSS % CNTB GROSS % HYPD FCF CNTB FCF
FY 2025 $813.5K $64.0K 62.7% — -$14.8M -$51.6M
FY 2024 $57.3K $26.0M -50.0% — -$30.3M -$24.4M
FY 2023 $3.8K $193.4M — — -$23.8M -$47.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HYPD // BETA —
CNTB // BETA —